A Better Way to Assess Quality of TAVR Care in the U.S.

A composite performance measure identified sites providing below-average care, amounting to 11% of all sites.

Quality of care in transcatheter aortic-valve replacement (TAVR) is currently measured by volume thresholds or arbitrarily chosen complications. These authors report the methodology and first results of an approach using clinically based benchmarking of quality of care, developed from data in the STS/ACC TVT Registry (which includes all patients undergoing commercial procedures for transcatheter valve replacement and repair in the U.S.).

After examination of data on 52,561 patients treated with TAVR in 301 hospitals between 2015 and 2017, the investigators created a hierarchical composite endpoint based on the strength of the associations between 30-day events and 1-year mortality and health status. The final hierarchical variables and their…

Reviewing Author

Howard C. Herrmann, MD

Disclosures

Consultant/Advisory BoardAffluent Medical; Artedrone; Caranx; Johnson & Johnson; Medtronic; Prolifagen; Wells Fargo

EquityMicrointerventional Devices, Inc.

RoyaltiesUniversity of Pennsylvania

Grant/Research SupportAbbott Vascular; Edwards Lifesciences; Johnson & Johnson; Medtronic

Editorial BoardsCatheterization and Cardiovascular Interventions; Journal of the American College of Cardiology; Circulation: Cardiovascular Interventions; JACC Cardiovascular Interventions; JACC Case Reports; JSCAI

Leadership Positions in Professional SocietiesHeart Valve Collaboratory (Scientific Committee Member, Chair of the Publications Committee)